SIBN.NASDAQSi-bone, INC

SCHEDULE: Cadian Capital Management Discloses SI-BONE Stake

Sentiment:

Beneficial Ownership Filing


Cadian Capital Management, LP, along with its affiliates, has reported beneficial ownership of approximately 7.5% of SI-BONE, Inc.'s common stock as of June 30, 2026.

Summary

  • Cadian Capital Management, LP, Cadian Capital Management GP, LLC, and Eric Bannasch (collectively, the 'Reporting Persons') have filed a Schedule 13G.
  • As of June 30, 2026, the Reporting Persons collectively beneficially owned 3,347,574 shares of SI-BONE, Inc. common stock.
  • This represents approximately 7.5% of the Issuer's outstanding common stock, based on 44,697,215 shares outstanding as of that date.
  • The securities are held by advisory clients of Cadian Capital Management, LP, which exercises exclusive voting and investment power.
  • Eric Bannasch is the sole managing member of Cadian Capital Management GP, LLC, the general partner of the investment adviser.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily an informational disclosure of beneficial ownership rather than a strategic announcement.

Positives

  • Significant ownership stake reported by a notable investment firm, potentially indicating confidence in the company's long-term prospects.
  • Clear disclosure of beneficial ownership, adhering to regulatory requirements and promoting transparency.

Negatives

  • The filing does not contain any negative financial or operational information, as it is purely an ownership disclosure.

Risks

  • Market volatility could impact the value of the reported stake.
  • Changes in investment strategy by Cadian Capital Management could lead to future sales of SI-BONE stock.

Future Outlook

This filing does not contain forward-looking statements or guidance from SI-BONE, Inc. It is a disclosure of beneficial ownership by Cadian Capital Management.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. This filing indicates Cadian Capital Management's position in the medical device sector, specifically within SI-BONE's niche.

Comparison to Industry Standards

  • The 7.5% ownership stake is a substantial position for an institutional investor, often considered a significant holding that may warrant further attention from other market participants.
  • Reporting Persons are classified as investment advisers (IA) and hedge funds (PN, OO, HC), which are standard classifications for entities managing pooled investment funds.

Stakeholder Impact

  • Shareholders: Increased transparency regarding significant ownership may influence investor sentiment.
  • Management of SI-BONE, Inc.: Awareness of a substantial institutional investor's position.
  • Competitors: May observe the investment activity of Cadian Capital Management in the sector.

Next Steps

  • The Reporting Persons will continue to monitor their investment in SI-BONE, Inc.
  • Further amendments to this Schedule 13G may be filed if there are changes in beneficial ownership.

Key Dates

DateDescription
2026-06-30Date as of which beneficial ownership is reported.
2026-08-04Date of SI-BONE's Form 10-Q filing disclosing outstanding shares.
2026-08-14Date of the Joint Filing Agreement and signatures on the Schedule 13G.

Keywords

SI-BONE, Schedule 13G, Beneficial Ownership, Cadian Capital Management, Investment Management, Stock Holdings, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.